CM
MDCO

Crestline Management’s Medicines Co MDCO Stock Holding History

Crestline Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,500
Closed -$638K – 123
2019
Q2 		$638K Buy
+17,500
New +$571K 0.09% 67

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Crestline Management's MDCO Position: Q3 2019 in Review

Crestline Management sold out of Medicines Co (MDCO) in Q3 2019, closing a stake of 17,500 shares — an estimated $638K sold.

Crestline Management first reported a position in MDCO in Q2 2019 and held it in 1 quarter. The position peaked at $638K in Q2 2019. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Crestline Management reported no remaining Medicines Co position as of Q3 2019 after selling out during the quarter.
  • Crestline Management sold 17,500 Medicines Co shares in Q3 2019, an estimated $638K.
  • Crestline Management first reported a position in Medicines Co in Q2 2019 and held it in 1 quarter.
  • Crestline Management's Medicines Co position peaked at $638K in Q2 2019.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.